Verastem: Approval Secured, Moving On To PDAC And KRAS G12D-Related Cancers

Verastem, Inc. ( VSTM ) is a company I've been on record as being optimistic about, through some challenging data readouts and uncertainty about drug approval . Now thatI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure ...